Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maxime Samson

Showing results (161-170 of 181) with videos related to

Pageof 19
Sort By:
Journal of the American Academy of Dermatology|November 7, 2022
Clinical and pathological features of cutaneous manifestations in VEXAS syndrome: A multicenter retrospective study of 59 casesÈve Zakine, Loula Papageorgiou, Rim Bourguiba, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 22, 2025
Comparative Efficacy and Safety of Anakinra and Canakinumab in Patients With VEXAS Syndrome: An International Multicenter StudyTali Eviatar, Dafne Capelusnik, Corrado Campochiaro, et al.
Journal of Autoimmunity|November 16, 2024
Glucocorticoids versus glucocorticoids plus cyclophosphamide in eosinophilic granulomatosis with polyangiitis with poor-prognosis factorsBoris Sorin, Matthias Papo, Renato A Sinico, et al.
Rheumatology (Oxford, England)|February 3, 2025
Association between large vessel vasculitis and inflammatory bowel disease: a case-control studyFrançois Maillet, Yann Nguyen, Olivier Espitia, et al.
Autoimmunity Reviews|May 7, 2019
Large-vessel vasculitis diagnosed between 50 and 60 years: Case-control study based on 183 cases and 183 controls aged over 60 yearsLaure Delaval, Aurélie Daumas, Maxime Samson, et al.
Rheumatology (Oxford, England)|May 24, 2025
Glucocorticoids vs glucocorticoids plus cyclophosphamide in eosinophilic granulomatosis with polyangiitis without poor-prognosis factors: a target trial emulation studyBoris Sorin, Matthias Papo, Renato Alberto Sinico, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 23, 2026
Prognosis and long term outcome of stenotic large vessel involvement in giant cell arteritisGeorgina Maalouf, Bérangère Arnould, Olivier Espitia, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|October 1, 2020
Use of Biologics to Treat Relapsing and/or Refractory Eosinophilic Granulomatosis With Polyangiitis: Data From a European Collaborative StudyAlice Canzian, Nils Venhoff, Maria Letizia Urban, et al.
Annals of the Rheumatic Diseases|November 2, 2023
Rituximab as maintenance therapy for ANCA-associated vasculitides: pooled analysis and long-term outcome of 277 patients included in the MAINRITSAN trialsFlorence Delestre, Pierre Charles, Alexandre Karras, et al.
Journal of Neurology|May 16, 2025
Correction: Neurological manifestations in patients with VEXAS syndromeCharlotte Bert-Marcaz, Étienne Fortanier, Antoine Briantais, et al.
Pageof 19

Showing results (161-170 of 181) with videos related to

Sort By:
Pageof 19
Journal of the American Academy of Dermatology|November 7, 2022
Clinical and pathological features of cutaneous manifestations in VEXAS syndrome: A multicenter retrospective study of 59 casesÈve Zakine, Loula Papageorgiou, Rim Bourguiba, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 22, 2025
Comparative Efficacy and Safety of Anakinra and Canakinumab in Patients With VEXAS Syndrome: An International Multicenter StudyTali Eviatar, Dafne Capelusnik, Corrado Campochiaro, et al.
Journal of Autoimmunity|November 16, 2024
Glucocorticoids versus glucocorticoids plus cyclophosphamide in eosinophilic granulomatosis with polyangiitis with poor-prognosis factorsBoris Sorin, Matthias Papo, Renato A Sinico, et al.
Rheumatology (Oxford, England)|February 3, 2025
Association between large vessel vasculitis and inflammatory bowel disease: a case-control studyFrançois Maillet, Yann Nguyen, Olivier Espitia, et al.
Autoimmunity Reviews|May 7, 2019
Large-vessel vasculitis diagnosed between 50 and 60 years: Case-control study based on 183 cases and 183 controls aged over 60 yearsLaure Delaval, Aurélie Daumas, Maxime Samson, et al.
Rheumatology (Oxford, England)|May 24, 2025
Glucocorticoids vs glucocorticoids plus cyclophosphamide in eosinophilic granulomatosis with polyangiitis without poor-prognosis factors: a target trial emulation studyBoris Sorin, Matthias Papo, Renato Alberto Sinico, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 23, 2026
Prognosis and long term outcome of stenotic large vessel involvement in giant cell arteritisGeorgina Maalouf, Bérangère Arnould, Olivier Espitia, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|October 1, 2020
Use of Biologics to Treat Relapsing and/or Refractory Eosinophilic Granulomatosis With Polyangiitis: Data From a European Collaborative StudyAlice Canzian, Nils Venhoff, Maria Letizia Urban, et al.
Annals of the Rheumatic Diseases|November 2, 2023
Rituximab as maintenance therapy for ANCA-associated vasculitides: pooled analysis and long-term outcome of 277 patients included in the MAINRITSAN trialsFlorence Delestre, Pierre Charles, Alexandre Karras, et al.
Journal of Neurology|May 16, 2025
Correction: Neurological manifestations in patients with VEXAS syndromeCharlotte Bert-Marcaz, Étienne Fortanier, Antoine Briantais, et al.
Pageof 19